Redwood Wealth Management Group’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-18,278
Closed -$295K 17
2026
Q1
$295K Sell
18,278
-1,745
-9% -$45.7K 0.13% 135
2025
Q4
$403K Buy
+20,023
New +$292K 0.17% 108
2024
Q3
Sell
-10,743
Closed -$69.3K 286
2024
Q2
$69.3K Buy
+10,743
New +$81.8K 0.05% 250
2024
Q1
Sell
-10,954
Closed -$102K 118
2023
Q4
$102K Sell
10,954
-2,226
-17% -$20.5K 0.11% 122
2023
Q3
$128K Sell
13,180
-68
-0.5% -$1.06K 0.15% 119
2023
Q2
$285K Buy
13,248
+56
+0.4% +$1.49K 0.32% 88
2023
Q1
$371K Buy
13,192
+1,343
+11% +$40.2K 0.42% 70
2022
Q4
$267K Buy
+11,849
New +$270K 0.33% 88

Other funds holding BNR

Redwood Wealth Management Group's BNR Position: Q2 2026 in Review

Redwood Wealth Management Group sold out of Burning Rock Biotech (BNR) in Q2 2026, closing a stake of 18,278 shares — an estimated $295K sold.

Redwood Wealth Management Group first reported a position in BNR in Q4 2022 and held it in 8 quarters. The position peaked at $403K in Q4 2025. 17 funds tracked by Wall St. Rank hold BNR as of Q2 2026.

  • Redwood Wealth Management Group reported no remaining Burning Rock Biotech position as of Q2 2026 after selling out during the quarter.
  • Redwood Wealth Management Group sold 18,278 Burning Rock Biotech shares in Q2 2026, an estimated $295K.
  • Redwood Wealth Management Group first reported a position in Burning Rock Biotech in Q4 2022 and held it in 8 quarters.
  • Redwood Wealth Management Group's Burning Rock Biotech position peaked at $403K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2026.

Based on Redwood Wealth Management Group's 13F filing for Q2 2026.